1. Home
  2. STT vs RMD Comparison

STT vs RMD Comparison

Compare STT & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STT
  • RMD
  • Stock Information
  • Founded
  • STT 1792
  • RMD 1989
  • Country
  • STT United States
  • RMD United States
  • Employees
  • STT N/A
  • RMD N/A
  • Industry
  • STT Major Banks
  • RMD Medical/Dental Instruments
  • Sector
  • STT Finance
  • RMD Health Care
  • Exchange
  • STT Nasdaq
  • RMD Nasdaq
  • Market Cap
  • STT 32.3B
  • RMD 36.4B
  • IPO Year
  • STT N/A
  • RMD 1995
  • Fundamental
  • Price
  • STT $115.21
  • RMD $251.34
  • Analyst Decision
  • STT Buy
  • RMD Buy
  • Analyst Count
  • STT 13
  • RMD 13
  • Target Price
  • STT $127.92
  • RMD $292.27
  • AVG Volume (30 Days)
  • STT 1.8M
  • RMD 1.4M
  • Earning Date
  • STT 10-17-2025
  • RMD 10-30-2025
  • Dividend Yield
  • STT 2.94%
  • RMD 0.96%
  • EPS Growth
  • STT 49.61
  • RMD 29.59
  • EPS
  • STT 9.43
  • RMD 9.77
  • Revenue
  • STT $13,626,000,000.00
  • RMD $5,257,400,000.00
  • Revenue This Year
  • STT $8.19
  • RMD $9.81
  • Revenue Next Year
  • STT $4.56
  • RMD $7.31
  • P/E Ratio
  • STT $12.12
  • RMD $25.66
  • Revenue Growth
  • STT 8.59
  • RMD 9.36
  • 52 Week Low
  • STT $72.81
  • RMD $199.92
  • 52 Week High
  • STT $122.69
  • RMD $293.81
  • Technical
  • Relative Strength Index (RSI)
  • STT 47.80
  • RMD 45.38
  • Support Level
  • STT $112.82
  • RMD $241.81
  • Resistance Level
  • STT $116.61
  • RMD $254.00
  • Average True Range (ATR)
  • STT 2.61
  • RMD 5.69
  • MACD
  • STT -0.51
  • RMD 0.88
  • Stochastic Oscillator
  • STT 30.02
  • RMD 64.81

About STT State Street Corporation

State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $49 trillion in assets under custody and administration, and $5.1 trillion in assets under management, as of June 30, 2025, State Street operates globally in more than 100 geographic markets and employs about 53,000 worldwide.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: